The Effects of Cytokines on Spontaneous Hepatitis B Surface Antigen Seroconversion in Chronic Hepatitis B Virus Infection

We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection. The clinical course of spontaneous HBsAg seroconversion was assessed in 296 chronically HBV-infected patients. Single nucleotide polymorphisms...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 194; no. 2; pp. 690 - 696
Main Authors Wu, Jia-Feng, Hsu, Hong-Yuan, Chiu, Yu-Chun, Chen, Huey-Ling, Ni, Yen-Hsuan, Chang, Mei-Hwei
Format Journal Article
LanguageEnglish
Published United States 15.01.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection. The clinical course of spontaneous HBsAg seroconversion was assessed in 296 chronically HBV-infected patients. Single nucleotide polymorphisms (SNPs) in IL-1β, IL-2, IL-4, IL-10, IL-12β, IL-13, IL-27, and IFN-γ genes were examined in 296 chronically HBV-infected patients and another 193 HBV recoverers. The HBsAg a determinant sequence of chronically HBV-infected subjects with and without HBsAg seroconversion was also analyzed. The start of the immune-clearance phase (serum alanine aminotransferase levels > 30 IU/l) before the age of 48 mo and hepatitis B e Ag (HBeAg) seroconversion before the age of 10 y predicted spontaneous HBsAg seroconversion in chronically HBV-infected patients (odds ratios 17.7 and 5.0; p < 0.001 and p < 0.002, respectively). The A-allele of IL-10 SNP rs1800872 was associated with higher IL-10 serum levels, and the G-allele of IL-12β SNP rs3212217 was associated with sustained high serum IL-12p70 levels during the immune-clearance phase. Both were predictors of spontaneous HBsAg seroconversion and HBV recovery (odds ratios 4.0 and 26.3; p = 0.002 and p < 0.001, respectively). Spontaneous HBsAg seroconversion was not related to sex, HBV genotype, or HBsAg a determinant mutation. The start of immune-clearance phase, age at HBeAg seroconversion, and serum IL-10 and IL-12 levels are associated with the course of the immune-clearance phase in chronic HBV infection, and are predictive of spontaneous HBsAg seroconversion and HBV recovery.
AbstractList We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection. The clinical course of spontaneous HBsAg seroconversion was assessed in 296 chronically HBV-infected patients. Single nucleotide polymorphisms (SNPs) in IL-1β, IL-2, IL-4, IL-10, IL-12β, IL-13, IL-27, and IFN-γ genes were examined in 296 chronically HBV-infected patients and another 193 HBV recoverers. The HBsAg a determinant sequence of chronically HBV-infected subjects with and without HBsAg seroconversion was also analyzed. The start of the immune-clearance phase (serum alanine aminotransferase levels > 30 IU/l) before the age of 48 mo and hepatitis B e Ag (HBeAg) seroconversion before the age of 10 y predicted spontaneous HBsAg seroconversion in chronically HBV-infected patients (odds ratios 17.7 and 5.0; p < 0.001 and p < 0.002, respectively). The A-allele of IL-10 SNP rs1800872 was associated with higher IL-10 serum levels, and the G-allele of IL-12β SNP rs3212217 was associated with sustained high serum IL-12p70 levels during the immune-clearance phase. Both were predictors of spontaneous HBsAg seroconversion and HBV recovery (odds ratios 4.0 and 26.3; p = 0.002 and p < 0.001, respectively). Spontaneous HBsAg seroconversion was not related to sex, HBV genotype, or HBsAg a determinant mutation. The start of immune-clearance phase, age at HBeAg seroconversion, and serum IL-10 and IL-12 levels are associated with the course of the immune-clearance phase in chronic HBV infection, and are predictive of spontaneous HBsAg seroconversion and HBV recovery.We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection. The clinical course of spontaneous HBsAg seroconversion was assessed in 296 chronically HBV-infected patients. Single nucleotide polymorphisms (SNPs) in IL-1β, IL-2, IL-4, IL-10, IL-12β, IL-13, IL-27, and IFN-γ genes were examined in 296 chronically HBV-infected patients and another 193 HBV recoverers. The HBsAg a determinant sequence of chronically HBV-infected subjects with and without HBsAg seroconversion was also analyzed. The start of the immune-clearance phase (serum alanine aminotransferase levels > 30 IU/l) before the age of 48 mo and hepatitis B e Ag (HBeAg) seroconversion before the age of 10 y predicted spontaneous HBsAg seroconversion in chronically HBV-infected patients (odds ratios 17.7 and 5.0; p < 0.001 and p < 0.002, respectively). The A-allele of IL-10 SNP rs1800872 was associated with higher IL-10 serum levels, and the G-allele of IL-12β SNP rs3212217 was associated with sustained high serum IL-12p70 levels during the immune-clearance phase. Both were predictors of spontaneous HBsAg seroconversion and HBV recovery (odds ratios 4.0 and 26.3; p = 0.002 and p < 0.001, respectively). Spontaneous HBsAg seroconversion was not related to sex, HBV genotype, or HBsAg a determinant mutation. The start of immune-clearance phase, age at HBeAg seroconversion, and serum IL-10 and IL-12 levels are associated with the course of the immune-clearance phase in chronic HBV infection, and are predictive of spontaneous HBsAg seroconversion and HBV recovery.
We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection. The clinical course of spontaneous HBsAg seroconversion was assessed in 296 chronically HBV-infected patients. Single nucleotide polymorphisms (SNPs) in IL-1 beta , IL-2, IL-4, IL-10, IL-12 beta , IL-13, IL-27, and IFN- gamma genes were examined in 296 chronically HBV-infected patients and another 193 HBV recoverers. The HBsAg a determinant sequence of chronically HBV-infected subjects with and without HBsAg seroconversion was also analyzed. The start of the immune-clearance phase (serum alanine aminotransferase levels > 30 IU/l) before the age of 48 mo and hepatitis B e Ag (HBeAg) seroconversion before the age of 10 y predicted spontaneous HBsAg seroconversion in chronically HBV-infected patients (odds ratios 17.7 and 5.0; p < 0.001 and p < 0.002, respectively). The A-allele of IL-10 SNP rs1800872 was associated with higher IL-10 serum levels, and the G-allele of IL-12 beta SNP rs3212217 was associated with sustained high serum IL-12p70 levels during the immune-clearance phase. Both were predictors of spontaneous HBsAg seroconversion and HBV recovery (odds ratios 4.0 and 26.3; p = 0.002 and p < 0.001, respectively). Spontaneous HBsAg seroconversion was not related to sex, HBV genotype, or HBsAg a determinant mutation. The start of immune-clearance phase, age at HBeAg seroconversion, and serum IL-10 and IL-12 levels are associated with the course of the immune-clearance phase in chronic HBV infection, and are predictive of spontaneous HBsAg seroconversion and HBV recovery.
We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection. The clinical course of spontaneous HBsAg seroconversion was assessed in 296 chronically HBV-infected patients. Single nucleotide polymorphisms (SNPs) in IL-1β, IL-2, IL-4, IL-10, IL-12β, IL-13, IL-27, and IFN-γ genes were examined in 296 chronically HBV-infected patients and another 193 HBV recoverers. The HBsAg a determinant sequence of chronically HBV-infected subjects with and without HBsAg seroconversion was also analyzed. The start of the immune-clearance phase (serum alanine aminotransferase levels > 30 IU/l) before the age of 48 mo and hepatitis B e Ag (HBeAg) seroconversion before the age of 10 y predicted spontaneous HBsAg seroconversion in chronically HBV-infected patients (odds ratios 17.7 and 5.0; p < 0.001 and p < 0.002, respectively). The A-allele of IL-10 SNP rs1800872 was associated with higher IL-10 serum levels, and the G-allele of IL-12β SNP rs3212217 was associated with sustained high serum IL-12p70 levels during the immune-clearance phase. Both were predictors of spontaneous HBsAg seroconversion and HBV recovery (odds ratios 4.0 and 26.3; p = 0.002 and p < 0.001, respectively). Spontaneous HBsAg seroconversion was not related to sex, HBV genotype, or HBsAg a determinant mutation. The start of immune-clearance phase, age at HBeAg seroconversion, and serum IL-10 and IL-12 levels are associated with the course of the immune-clearance phase in chronic HBV infection, and are predictive of spontaneous HBsAg seroconversion and HBV recovery.
Author Chen, Huey-Ling
Hsu, Hong-Yuan
Chiu, Yu-Chun
Chang, Mei-Hwei
Wu, Jia-Feng
Ni, Yen-Hsuan
Author_xml – sequence: 1
  givenname: Jia-Feng
  surname: Wu
  fullname: Wu, Jia-Feng
– sequence: 2
  givenname: Hong-Yuan
  surname: Hsu
  fullname: Hsu, Hong-Yuan
– sequence: 3
  givenname: Yu-Chun
  surname: Chiu
  fullname: Chiu, Yu-Chun
– sequence: 4
  givenname: Huey-Ling
  surname: Chen
  fullname: Chen, Huey-Ling
– sequence: 5
  givenname: Yen-Hsuan
  surname: Ni
  fullname: Ni, Yen-Hsuan
– sequence: 6
  givenname: Mei-Hwei
  surname: Chang
  fullname: Chang, Mei-Hwei
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25505294$$D View this record in MEDLINE/PubMed
BookMark eNqFkc9PHCEYhomx0dX23pPh6GUsMMAwR934KzHpQdsrmWE-KjoDKzAm-9_LZncPNWl6-kLyPO-Xj_cEHfrgAaHvlFxwwtsfL26aZh_GC8oJlaI9QAsqBKmkJPIQLQhhrKKNbI7RSUovhBBJGD9Cx6xAgrV8gdZPz4CvrQWTEw4WL9c5vDoP5eHx4yr43HkIc8J3sOqyyy7hK_w4R9sZwJc-uz9QOIjBBP8OMbmiOY-XzzF4Z_6yfrtYcu79ZlfBvqIvthsTfNvNU_Tr5vppeVc9_Ly9X14-VKauWa5sPQzUDKxnHWdUUd4zYnrDFe-FMYwOjbFcQc15C0pYJmoxiMZSpRQwDrI-Refb3FUMbzOkrCeXDIzj9jBNFVGybpu2-T8qOZOkaQUr6NkOnfsJBr2KburiWu9_tgByC5gYUopgtXG52xyeY-dGTYneVKj3FepdhUUkn8R99j-VD5Xroas
CitedBy_id crossref_primary_10_1055_a_2153_8836
crossref_primary_10_2147_JIR_S411492
crossref_primary_10_1186_s12929_015_0199_y
crossref_primary_10_4254_wjh_v7_i30_2980
crossref_primary_10_1016_j_jhepr_2024_101061
crossref_primary_10_1093_infdis_jiy048
crossref_primary_10_3389_fmolb_2021_805625
crossref_primary_10_1016_j_cgh_2022_02_046
crossref_primary_10_1002_hep_28222
crossref_primary_10_1002_iid3_70017
crossref_primary_10_1038_srep37015
crossref_primary_10_3389_fimmu_2022_1104329
crossref_primary_10_1002_jmv_24518
crossref_primary_10_1007_s00535_021_01840_w
crossref_primary_10_1186_s12879_019_3853_2
crossref_primary_10_1002_jmv_24572
crossref_primary_10_12677_ACM_2023_13112604
crossref_primary_10_1111_hepr_12726
crossref_primary_10_1186_s40001_016_0218_9
crossref_primary_10_1016_j_cgh_2024_07_036
crossref_primary_10_1097_MD_0000000000001435
crossref_primary_10_1016_j_intimp_2022_108982
crossref_primary_10_1155_2019_6915850
crossref_primary_10_1038_s41598_023_50216_y
Cites_doi 10.1097/01.LAB.0000087589.37269.FC
10.1093/infdis/jir852
10.1016/j.jhep.2004.06.031
10.1128/jvi.71.1.345-353.1997
10.1002/hep.20888
10.1002/hep.23983
10.1371/journal.pone.0053008
10.1203/01.PDR.0000130480.51066.FB
10.1371/journal.ppat.1003208
10.1128/JVI.77.23.12875-12880.2003
10.1111/j.1440-1746.2007.04846.x
10.1056/NEJM199504203321604
10.1111/j.1478-3231.2010.02340.x
10.1016/S0168-8278(00)80078-1
10.1002/hep.21077
10.1053/j.gastro.2011.04.046
10.1128/jvi.74.10.4729-4737.2000
10.1016/S1470-2045(13)70350-4
10.1111/j.1572-0241.2002.05926.x
10.1086/341508
10.1097/MPG.0b013e31822a033e
10.1053/j.gastro.2009.09.018
10.1016/j.ajpath.2012.03.036
10.1016/j.jhep.2008.09.017
10.1093/cid/cir755
10.1371/journal.pone.0039175
10.1111/j.1478-3231.2011.02481.x
10.1016/S0140-6736(81)90585-7
10.3851/IMP1497
10.1002/hep.1840150304
10.1002/hep.510260336
10.4049/jimmunol.177.12.8633
ContentType Journal Article
Copyright Copyright © 2015 by The American Association of Immunologists, Inc.
Copyright_xml – notice: Copyright © 2015 by The American Association of Immunologists, Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
7U7
7U9
C1K
H94
DOI 10.4049/jimmunol.1401659
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList MEDLINE - Academic
AIDS and Cancer Research Abstracts
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 696
ExternalDocumentID 25505294
10_4049_jimmunol_1401659
Genre Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.55
0R~
18M
2WC
34G
39C
53G
5GY
5RE
5VS
5WD
79B
85S
AARDX
AAYXX
ABCQX
ABDFA
ABEJV
ABGNP
ABJNI
ABOCM
ABPPZ
ABXVV
ACGFO
ACGFS
ACIWK
ACNCT
ACPRK
ADBBV
ADIPN
ADNWM
AENEX
AETEA
AFHIN
AFOSN
AFRAH
AGORE
AHMMS
AHWXS
AIZAD
ALMA_UNASSIGNED_HOLDINGS
ARBBW
BAWUL
BCRHZ
BTFSW
CITATION
D0L
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
IH2
K-O
KOP
KQ8
L7B
OCZFY
OK1
OWPYF
P0W
P2P
PQQKQ
R.V
RHI
ROX
RZQ
SJN
TR2
TWZ
W8F
WH7
WOQ
X7M
XJT
XSW
XTH
YHG
CGR
CUY
CVF
ECM
EIF
NPM
7X8
FRP
7T5
7U7
7U9
C1K
H94
ID FETCH-LOGICAL-c332t-f3dd1cd2b2a421814b20cbc484b5cc21d7cf48e3449e85f2535d57f1888e24e63
ISSN 0022-1767
1550-6606
IngestDate Tue Aug 05 10:33:16 EDT 2025
Fri Jul 11 15:42:07 EDT 2025
Mon Jul 21 06:03:40 EDT 2025
Tue Aug 05 12:14:30 EDT 2025
Thu Apr 24 23:01:48 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License https://academic.oup.com/pages/standard-publication-reuse-rights
Copyright © 2015 by The American Association of Immunologists, Inc.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c332t-f3dd1cd2b2a421814b20cbc484b5cc21d7cf48e3449e85f2535d57f1888e24e63
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 25505294
PQID 1642607952
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_1808639797
proquest_miscellaneous_1642607952
pubmed_primary_25505294
crossref_citationtrail_10_4049_jimmunol_1401659
crossref_primary_10_4049_jimmunol_1401659
PublicationCentury 2000
PublicationDate 2015-01-15
2015-Jan-15
20150115
PublicationDateYYYYMMDD 2015-01-15
PublicationDate_xml – month: 01
  year: 2015
  text: 2015-01-15
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of immunology (1950)
PublicationTitleAlternate J Immunol
PublicationYear 2015
References Yeh (2025030704313093800_r17) 2004; 41
Wu (2025030704313093800_r12) 2012; 54
Mack (2025030704313093800_r26) 2004; 56
Su (2025030704313093800_r19) 2012; 205
Schurich (2025030704313093800_r27) 2013; 9
Cheng (2025030704313093800_r10) 2013; 8
Mu (2025030704313093800_r20) 2009; 50
Lin (2025030704313093800_r22) 1989; 9
Lertkhachonsuk (2025030704313093800_r2) 2013; 14
Wu (2025030704313093800_r15) 2010; 138
Hsu (2025030704313093800_r4) 1992; 15
Kao (2025030704313093800_r13) 2010; 30
Takakura (2025030704313093800_r14) 2007; 22
Tseng (2025030704313093800_r5) 2011; 141
Bortolotti (2025030704313093800_r7) 2006; 43
Nishida (2025030704313093800_r9) 2012; 7
Miyazoe (2025030704313093800_r24) 2002; 97
Jin (2025030704313093800_r34) 2011; 53
Lainé (2025030704313093800_r31) 2003; 77
Bozkaya (2025030704313093800_r23) 2000; 47
Ethuin (2025030704313093800_r28) 2003; 83
Rigopoulou (2025030704313093800_r29) 2005; 42
Marx (2025030704313093800_r6) 2002; 186
Hsu (2025030704313093800_r18) 1997; 26
Cameron (2025030704313093800_r33) 2006; 177
Beasley (2025030704313093800_r1) 1981; 2
Thursz (2025030704313093800_r8) 1995; 332
Chu (2025030704313093800_r3) 2010; 15
Carreño (2025030704313093800_r30) 2000; 32
Scaglioni (2025030704313093800_r32) 1997; 71
Shi (2025030704313093800_r21) 2012; 32
Santin (2025030704313093800_r25) 2000; 74
Wu (2025030704313093800_r16) 2012; 181
Chu (2025030704313093800_r11) 2012; 54
References_xml – volume: 83
  start-page: 1353
  year: 2003
  ident: 2025030704313093800_r28
  article-title: Regulation of interleukin 12 p40 and p70 production by blood and alveolar phagocytes during severe sepsis
  publication-title: Lab. Invest.
  doi: 10.1097/01.LAB.0000087589.37269.FC
– volume: 205
  start-page: 757
  year: 2012
  ident: 2025030704313093800_r19
  article-title: Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in Taiwan
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jir852
– volume: 41
  start-page: 659
  year: 2004
  ident: 2025030704313093800_r17
  article-title: Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2004.06.031
– volume: 71
  start-page: 345
  year: 1997
  ident: 2025030704313093800_r32
  article-title: Posttranscriptional regulation of hepatitis B virus replication by the precore protein
  publication-title: J. Virol.
  doi: 10.1128/jvi.71.1.345-353.1997
– volume: 42
  start-page: 1028
  year: 2005
  ident: 2025030704313093800_r29
  article-title: Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity
  publication-title: Hepatology
  doi: 10.1002/hep.20888
– volume: 53
  start-page: 219
  year: 2011
  ident: 2025030704313093800_r34
  article-title: Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells
  publication-title: Hepatology
  doi: 10.1002/hep.23983
– volume: 8
  start-page: e53008
  year: 2013
  ident: 2025030704313093800_r10
  article-title: Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0053008
– volume: 56
  start-page: 79
  year: 2004
  ident: 2025030704313093800_r26
  article-title: Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation
  publication-title: Pediatr. Res.
  doi: 10.1203/01.PDR.0000130480.51066.FB
– volume: 9
  start-page: e1003208
  year: 2013
  ident: 2025030704313093800_r27
  article-title: The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1003208
– volume: 77
  start-page: 12875
  year: 2003
  ident: 2025030704313093800_r31
  article-title: In vitro and in vivo interactions between the hepatitis B virus protein P22 and the cellular protein gC1qR
  publication-title: J. Virol.
  doi: 10.1128/JVI.77.23.12875-12880.2003
– volume: 22
  start-page: 1271
  year: 2007
  ident: 2025030704313093800_r14
  article-title: Possible involvement of cytokine gene polymorphisms in fulminant hepatitis
  publication-title: J. Gastroenterol. Hepatol.
  doi: 10.1111/j.1440-1746.2007.04846.x
– volume: 332
  start-page: 1065
  year: 1995
  ident: 2025030704313093800_r8
  article-title: Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199504203321604
– volume: 9
  start-page: 737
  year: 1989
  ident: 2025030704313093800_r22
  article-title: Hepatitis B virus markers in Chinese twins
  publication-title: Anticancer Res.
– volume: 30
  start-page: 1448
  year: 2010
  ident: 2025030704313093800_r13
  article-title: Tumour necrosis factor-α promoter region polymorphisms affect the course of spontaneous HBsAg clearance
  publication-title: Liver Int.
  doi: 10.1111/j.1478-3231.2010.02340.x
– volume: 32
  start-page: 317
  year: 2000
  ident: 2025030704313093800_r30
  article-title: A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B
  publication-title: J. Hepatol.
  doi: 10.1016/S0168-8278(00)80078-1
– volume: 43
  start-page: 556
  year: 2006
  ident: 2025030704313093800_r7
  article-title: Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study
  publication-title: Hepatology
  doi: 10.1002/hep.21077
– volume: 141
  start-page: 517
  year: 2011
  ident: 2025030704313093800_r5
  article-title: Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2011.04.046
– volume: 74
  start-page: 4729
  year: 2000
  ident: 2025030704313093800_r25
  article-title: Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes
  publication-title: J. Virol.
  doi: 10.1128/jvi.74.10.4729-4737.2000
– volume: 14
  start-page: e497
  year: 2013
  ident: 2025030704313093800_r2
  article-title: Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(13)70350-4
– volume: 47
  start-page: 1675
  year: 2000
  ident: 2025030704313093800_r23
  article-title: Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease
  publication-title: Hepatogastroenterology
– volume: 97
  start-page: 2086
  year: 2002
  ident: 2025030704313093800_r24
  article-title: Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus
  publication-title: Am. J. Gastroenterol.
  doi: 10.1111/j.1572-0241.2002.05926.x
– volume: 186
  start-page: 295
  year: 2002
  ident: 2025030704313093800_r6
  article-title: Long-term follow-up of chronic hepatitis B virus infection in children of different ethnic origins
  publication-title: J. Infect. Dis.
  doi: 10.1086/341508
– volume: 54
  start-page: 97
  year: 2012
  ident: 2025030704313093800_r12
  article-title: Predictive effect of serial serum alanine aminotransferase levels on spontaneous HBeAg seroconversion in chronic genotype B and C HBV-infected children
  publication-title: J. Pediatr. Gastroenterol. Nutr.
  doi: 10.1097/MPG.0b013e31822a033e
– volume: 138
  start-page: 165
  year: 2010
  ident: 2025030704313093800_r15
  article-title: Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2009.09.018
– volume: 181
  start-page: 19
  year: 2012
  ident: 2025030704313093800_r16
  article-title: Suppression of furin by interferon-γ and the impact on hepatitis B virus antigen biosynthesis in human hepatocytes
  publication-title: Am. J. Pathol.
  doi: 10.1016/j.ajpath.2012.03.036
– volume: 50
  start-page: 264
  year: 2009
  ident: 2025030704313093800_r20
  article-title: Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2008.09.017
– volume: 54
  start-page: 88
  year: 2012
  ident: 2025030704313093800_r11
  article-title: Prevalence of and risk factors for hepatitis B viremia after spontaneous hepatitis B surface antigen seroclearance in hepatitis B carriers
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/cir755
– volume: 7
  start-page: e39175
  year: 2012
  ident: 2025030704313093800_r9
  article-title: Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0039175
– volume: 32
  start-page: 231
  year: 2012
  ident: 2025030704313093800_r21
  article-title: Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis
  publication-title: Liver Int.
  doi: 10.1111/j.1478-3231.2011.02481.x
– volume: 2
  start-page: 1129
  year: 1981
  ident: 2025030704313093800_r1
  article-title: Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan
  publication-title: Lancet
  doi: 10.1016/S0140-6736(81)90585-7
– volume: 15
  start-page: 133
  year: 2010
  ident: 2025030704313093800_r3
  article-title: Hepatitis B surface antigen seroclearance during chronic HBV infection
  publication-title: Antivir. Ther. (Lond.)
  doi: 10.3851/IMP1497
– volume: 15
  start-page: 382
  year: 1992
  ident: 2025030704313093800_r4
  article-title: Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection
  publication-title: Hepatology
  doi: 10.1002/hep.1840150304
– volume: 26
  start-page: 786
  year: 1997
  ident: 2025030704313093800_r18
  article-title: Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis
  publication-title: Hepatology
  doi: 10.1002/hep.510260336
– volume: 177
  start-page: 8633
  year: 2006
  ident: 2025030704313093800_r33
  article-title: Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.177.12.8633
SSID ssj0006024
Score 2.2895384
Snippet We examined the role of human cytokines in the natural course of hepatitis B surface Ag (HBsAg) seroconversion in chronic hepatitis B virus (HBV) infection....
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 690
SubjectTerms Adult
Cross-Sectional Studies
Cytokines - genetics
Cytokines - immunology
Female
Follow-Up Studies
Hepatitis B e Antigens - genetics
Hepatitis B e Antigens - immunology
Hepatitis B virus
Hepatitis B virus - genetics
Hepatitis B virus - immunology
Hepatitis B, Chronic - genetics
Hepatitis B, Chronic - immunology
Hepatitis B, Chronic - pathology
Humans
Immunity, Cellular - genetics
Male
Middle Aged
Mutation
Polymorphism, Single Nucleotide
Retrospective Studies
Title The Effects of Cytokines on Spontaneous Hepatitis B Surface Antigen Seroconversion in Chronic Hepatitis B Virus Infection
URI https://www.ncbi.nlm.nih.gov/pubmed/25505294
https://www.proquest.com/docview/1642607952
https://www.proquest.com/docview/1808639797
Volume 194
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEIgXBANGuclI8IAqd4njOM4jK6ByGU-b2J6ixHHWCkimNkEqf4E_jY_tpMnEJuAlquwkbv19PT7HPheEXvhFzIVWo4koMk5YHPgkLryYcJGGIshFwDIIFD78zOfH7MNJeDIa_ep5LTV1NpU__xhX8j-o6jaNK0TJ_gOy3Ut1g_6s8dVXjbC-_jXGPYcMuamrr-DGDicA4PqqFT8FLq4LBX7T9XI9OZism1WRmiiBGhJxTvQXrYzrudk3g-0PafPlDp76sVw1W8-tsq_SboPLbP4JCDixiZ1emuMzr7fZ8KUxrFmmRM_jWUeptWmeV-UZOW22dJ0tlqbjtCGzRdNrtqJy3qgN-dQuvW7nwgcnQWJjN6fKSdtQ267c4wNxbIseO97RnnDltrDoRaHPtJEDQt_9vimYjNymGe9x4Py7IQEFi4y6IYaJttuua-g61TYHlMN48_5jt6xzrc3Yc24YcP_icJBV2r1gqOJcYrcY_eXoDrrtEMKvLYvuopEqd9ENW4p0s4tuHjoni3sIahliRytcFbijFa5K3KMV7giCD7CjFXa0wkNa4WWJHa0GTxla4Y5W99Hxu7dHszlxFTqIDAJakyLIc1_mNKMpA12RZdSTmWSCZaGU1M8jWTChAsZiJcKChkGYh1HhCyEUZYoHD9BOWZXqIcK-SHMa8Uir81Ib7YXI4iDW6xFNY1qIkI3RfjupiXTp66GKyrdEm7GASNIikjhExuhV98S5Td1yxb3PW5wSLV_h0MxOZeJzqOEQxSG94h7hCXNAHo3RngW5G7ElxaNLex6jW9t_xxO0U68a9VRrunX2zDDwNxI0rJ8
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effects+of+cytokines+on+spontaneous+hepatitis+B+surface+antigen+seroconversion+in+chronic+hepatitis+B+virus+infection&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Wu%2C+Jia-Feng&rft.au=Hsu%2C+Hong-Yuan&rft.au=Chiu%2C+Yu-Chun&rft.au=Chen%2C+Huey-Ling&rft.date=2015-01-15&rft.eissn=1550-6606&rft.volume=194&rft.issue=2&rft.spage=690&rft_id=info:doi/10.4049%2Fjimmunol.1401659&rft_id=info%3Apmid%2F25505294&rft.externalDocID=25505294
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon